Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer

NCT01149174

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Dept. of Surgery, Tor Vergata University Rome, Italy

View Trial Details

Completed

Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors

NCT00335491

Conditions: Adnexal Diseases, Bladder Cancer, Breast Cancer, +68 more
Locations: Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States

View Trial Details

Completed

Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer

NCT01442519

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Dept. of Surgery/Urology, Tor Vergata University Rome, RM, Italy

View Trial Details

Completed

Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma

NCT00277017

Conditions: Adenocarcinoma, Cancer, Carcinoma, +15 more
Locations: Lovelace Sandia Health Systems Dept of Hematology Albuquerque, New Mexico, United States

University of New Mexico Albuquerque, New Mexico, United States

New Mexico Cancer Care Associates Santa Fe, New Mexico, United States

View Trial Details

Completed

Phase 1 Study of OSI-930 in Cancer Patients

NCT00513851

Conditions: Adnexal Diseases, Advanced Solid Tumors, Bronchial Neoplasms, +49 more
Locations: University of Colorado Cancer Center Aurora, Colorado, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Cancer Research UK Professor of Medical Oncology Sutton, Surrey, United Kingdom

View Trial Details

Completed

Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)

NCT00267748

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Pfizer Investigational Site Hot Springs, Arkansas, United States

Pfizer Investigational Site Little Rock, Arkansas, United States

Pfizer Investigational Site Anaheim, California, United States

Pfizer Investigational Site Baldwin Park, California, United States

View all 156 locations

View Trial Details

Completed

Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)

NCT00693927

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: CHU Sart Tilman Liège, Liege, Belgium

View Trial Details

Completed

Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma

NCT00113529

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Pfizer Investigational Site Ann Arbor, Michigan, United States

Pfizer Investigational Site New York, United States

Pfizer Investigational Site Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC)

NCT00478114

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Siriraj Hospital, Department of Medicine Bangkoknoi, Bangkok, Thailand

View Trial Details

Completed

Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes

NCT00393029

Conditions: Adenocarcinoma, Anti-p53 TCR-Gene, Carcinoma, +18 more
Locations: National Institutes of Health Bethesda, Maryland, United States

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions